Helenalin_NN
,_,
an_DT
anti-inflammatory_JJ
sesquiterpene_NN
lactone_NN
from_IN
Arnica_FW
,_,
selectively_RB
inhibits_VBZ
transcription_NN
factor_NN
NF-kappaB_NN
-LCB-_-LRB-
see_VB
comments_NNS
-RCB-_-RRB-

Alcoholic_JJ
extracts_NNS
prepared_VBN
form_IN
Arnicae_FW
flos_FW
,_,
the_DT
collective_JJ
name_NN
for_IN
flowerheads_NNS
from_IN
Arnica_FW
montana_FW
and_CC
A._FW
chamissonis_FW
ssp_NN
._.
foliosa_NN
,_,
are_VBP
used_VBN
therapeutically_RB
as_IN
anti-inflammatory_JJ
remedies_NNS
._.

The_DT
active_JJ
ingredients_NNS
mediating_VBG
the_DT
pharmacological_JJ
effect_NN
are_VBP
mainly_RB
sesquiterpene_NN
lactones_NNS
,_,
such_JJ
as_IN
helenalin_NN
,_,
11alpha,13-dihydrohelenalin_NN
,_,
chamissonolid_NN
and_CC
their_PRP$
ester_NN
derivatives_NNS
._.

While_IN
these_DT
compounds_NNS
affect_VBP
various_JJ
cellular_JJ
processes_NNS
,_,
current_JJ
data_NNS
do_VBP
not_RB
fully_RB
explain_VB
how_WRB
sesquiterpene_NN
lactones_NNS
exert_VBP
their_PRP$
anti-inflammatory_JJ
effect_NN
._.

We_PRP
show_VBP
here_RB
that_IN
helenalin_NN
,_,
and_CC
,_,
to_TO
a_DT
much_RB
lesser_JJR
degree_NN
,_,
11alpha,13-dihydrohelenalin_NN
and_CC
chamissonolid_NN
,_,
inhibit_VBP
activation_NN
of_IN
transcription_NN
factor_NN
NF-kappaB_NN
._.

This_DT
difference_NN
in_IN
efficacy_NN
,_,
which_WDT
correlates_VBZ
with_IN
the_DT
compounds_NNS
'_POS
anti-inflammatory_JJ
potency_NN
in_FW
vivo_FW
,_,
may_MD
be_VB
explained_VBN
by_IN
differences_NNS
in_IN
structure_NN
and_CC
conformation_NN
._.

NF-kappaB_NN
,_,
which_WDT
resides_VBZ
in_IN
an_DT
inactive_JJ
,_,
cytoplasmic_JJ
complex_NN
in_IN
unstimulated_JJ
cells_NNS
,_,
is_VBZ
activated_VBN
by_IN
phosphorylation_NN
and_CC
degradation_NN
of_IN
its_PRP$
inhibitory_JJ
subunit_NN
,_,
IkappaB_NN
._.

Helenalin_NN
inhibits_VBZ
NF-kappaB_NN
activation_NN
in_IN
response_NN
to_TO
four_CD
different_JJ
stimuli_NNS
in_IN
T-cells_NNS
,_,
B-cells_NNS
and_CC
epithelial_JJ
cells_NNS
and_CC
abrogates_VBZ
kappaB-driven_JJ
gene_NN
expression_NN
._.

This_DT
inhibition_NN
is_VBZ
selective_JJ
,_,
as_IN
the_DT
activity_NN
of_IN
four_CD
other_JJ
transcription_NN
factors_NNS
,_,
Oct-1_NN
,_,
TBP_NN
,_,
Sp1_NN
and_CC
STAT_NN
5_CD
was_VBD
not_RB
affected_VBN
._.

We_PRP
show_VBP
that_IN
inhibition_NN
is_VBZ
not_RB
due_JJ
to_TO
a_DT
direct_JJ
modification_NN
of_IN
the_DT
active_JJ
NF-kappaB_NN
heterodimer_NN
._.

Rather_RB
,_,
helenalin_NN
modifies_VBZ
the_DT
NF-kappaB\/IkappaB_JJ
complex_NN
,_,
preventing_VBG
the_DT
release_NN
of_IN
IkappaB_NN
._.

These_DT
data_NNS
suggest_VBP
a_DT
molecular_JJ
mechanism_NN
for_IN
the_DT
anti-inflammatory_JJ
effect_NN
of_IN
sesquiterpene_NN
lactones_NNS
,_,
which_WDT
differs_VBZ
from_IN
that_DT
of_IN
other_JJ
nonsteroidal_JJ
anti-inflammatory_JJ
drugs_NNS
-LRB-_-LRB-
NSAIDs_NNS
-RRB-_-RRB-
,_,
indomethacin_NN
and_CC
acetyl_NN
salicylic_JJ
acid_NN
._.

